Phase 2 Study to Evaluate Safety & Efficacy of RM-131 Administered to Patients With Diabetic Gastroparesis
Last updated on July 2021Recruitment
- Recruitment Status
- Completed
- Estimated Enrollment
- 125
Summary
- Conditions
- Diabetes Mellitus
- Diabetes Mellitus Complications
- Gastroparesis
- Type
- Interventional
- Phase
- Phase 2
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Double (Participant, Investigator)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 75 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT01571297
- Collaborators
- Not Provided
- Investigators
- Study Director: Chief Development Officer Rhythm Pharmaceuticals, Inc.
Get Well Soon